| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2015 | US20150005251 Substituted nucleosides, nucleotides and analogs thereof |
| 01/01/2015 | US20150005250 Telomerase reverse transcriptase deficiency as diagnostic marker of myelodysplastic syndrome |
| 01/01/2015 | US20150005249 Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation |
| 01/01/2015 | US20150005246 Use of Jasmonate to Treat Bladder Dysfunction |
| 01/01/2015 | US20150005244 Pharmaceutical formulations |
| 01/01/2015 | US20150005232 Indazole derivatives |
| 01/01/2015 | US20150004696 Inhibiting cyclin d polypeptides |
| 01/01/2015 | US20150004626 Protein Target Complex |
| 01/01/2015 | US20150004304 SOLUBILIZED CoQ-10 |
| 01/01/2015 | US20150004268 Fat-based food products |
| 01/01/2015 | US20150004261 Rhizoma Arisaematis Extracts and Uses Thereof for Wound-Healing Effects |
| 01/01/2015 | US20150004260 Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extract |
| 01/01/2015 | US20150004259 Nitroxyl progenitors in the treatment of heart failure |
| 01/01/2015 | US20150004255 Peritoneal dialysis fluid comprising a gsk-3 inhibitor |
| 01/01/2015 | US20150004252 Method for predicting the clinical response to chemotherapy in a subject with cancer |
| 01/01/2015 | US20150004251 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 01/01/2015 | US20150004250 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 01/01/2015 | US20150004244 Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| 01/01/2015 | US20150004243 Oil-in-water method for making polymeric implants containing a hypotensive lipid |
| 01/01/2015 | US20150004242 Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease |
| 01/01/2015 | US20150004240 Compositions and methods of making rapidly dissolving ionically masked formulations |
| 01/01/2015 | US20150004239 Pharmaceutical compositions and methods for their preparation |
| 01/01/2015 | US20150004238 Emulsions providing stable vitamin compositions and methods of forming compositions thereof |
| 01/01/2015 | US20150004237 Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs |
| 01/01/2015 | US20150004236 Efficient process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption |
| 01/01/2015 | US20150004234 Nanoparticulate compositions and formulations of piperazine compounds |
| 01/01/2015 | US20150004233 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| 01/01/2015 | US20150004232 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 01/01/2015 | US20150004231 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 01/01/2015 | US20150004229 Combined pharmaceutical formulation containing diacerein |
| 01/01/2015 | US20150004228 Pharmaceutical compositions containing flibanserin |
| 01/01/2015 | US20150004226 Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| 01/01/2015 | US20150004225 Pharmaceutical Dosage Form |
| 01/01/2015 | US20150004224 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
| 01/01/2015 | US20150004219 Stable liposomes for drug delivery |
| 01/01/2015 | US20150004216 Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
| 01/01/2015 | US20150004215 Method for producing patch, patch and package |
| 01/01/2015 | US20150004214 Vaginal ring comprising dhea or dhea sulfate and optionally a release-modulating agent of the active principle, useful to increase the ovarian reserve in women and to relieve symptoms associated with menopause |
| 01/01/2015 | US20150004212 Linear polyesteramides from aminophenolic esters |
| 01/01/2015 | US20150004206 Microparticles comprising pcl and uses thereof |
| 01/01/2015 | US20150004198 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 01/01/2015 | US20150004193 Novel dna-origami nanovaccines |
| 01/01/2015 | US20150004181 Benzazole Derivatives as Histamine H4 Receptor Ligands |
| 01/01/2015 | US20150004180 Method for Inducing a TRIF-Bias |
| 01/01/2015 | US20150004175 Compositions and Methods for Reducing CTL Exhaustion |
| 01/01/2015 | US20150004163 Adjuvant combinations comprising an nkt activator, a cd40 agent, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 01/01/2015 | US20150004156 Novel pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type ii |
| 01/01/2015 | US20150004154 Regimen for suppressing organ rejection |
| 01/01/2015 | US20150004148 Methods and compositions for increasing rna interference |
| 01/01/2015 | US20150004147 Lactose Compositions With Decreased Lactose Content |
| 01/01/2015 | US20150004140 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans |
| 01/01/2015 | US20150004135 2'-4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/01/2015 | US20150004134 Treatment of cancer with heterocyclic inhibitors of glutaminase |
| 01/01/2015 | US20150004128 Targeted drug phosphorylcholine polymer conjugates |
| 01/01/2015 | US20150004106 ACNE treatment method |
| 01/01/2015 | US20150004102 Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof |
| 01/01/2015 | US20150004097 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 12/31/2014 | CN204050374U 一种脂肪乳尾液处理装置 Last one kind of fat emulsion fluid processing apparatus |
| 12/31/2014 | CN204049919U 一种口腔喷雾器 An oral sprayer |
| 12/31/2014 | CN204049918U 口腔喷雾器 Oral sprayer |
| 12/31/2014 | CN104254607A 用于调节mir-21活性的微小rna化合物及方法 Mir-21 for modulating the activity of the compounds and methods micro rna |
| 12/31/2014 | CN104254539A 抗糖尿病的氨基甾族化合物衍生物 Amino steroid derivative antidiabetic |
| 12/31/2014 | CN104254537A 用于治疗性功能障碍的Phragmalin柠檬苦素类化合物 Phragmalin limonoids compounds for the treatment of sexual dysfunction |
| 12/31/2014 | CN104254535A 取代的吡唑并[1,5-a]吡啶、其制备及作为药物的应用 Substituted pyrazolo [1,5-a] pyridine, its preparation and use as medicaments |
| 12/31/2014 | CN104254534A Hec1活性的改善的调控剂及其方法 Hec1 improved activity modulators and methods |
| 12/31/2014 | CN104254533A 用作激酶抑制剂的噻唑或噻二唑取代的吡啶基化合物 Are useful as kinase inhibitors thiazole or thiadiazole substituted pyridyl compound |
| 12/31/2014 | CN104254532A 磷酸肌醇3-激酶抑制剂 Phosphoinositide 3-kinase inhibitor |
| 12/31/2014 | CN104254531A 环状二氨基嘧啶衍生物 Cyclic diaminopyrimidine derivative |
| 12/31/2014 | CN104254530A 苯并噻吩化合物或其盐的二水合物及其制备方法 Dihydrate and its preparation method benzothiophene compound or a salt thereof |
| 12/31/2014 | CN104254528A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 12/31/2014 | CN104254527A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 12/31/2014 | CN104254526A 针对结核病的新的抗分枝杆菌药物 For a new anti-tuberculosis mycobacterial drugs |
| 12/31/2014 | CN104254525A 芳环化合物 Aromatic compounds |
| 12/31/2014 | CN104254524A 含有岩藻黄质的组合物的制造方法 The method comprises producing fucoxanthin composition |
| 12/31/2014 | CN104254522A 作为trpv3调节剂的甲醇衍生物 As modulators of the carbinol derivative trpv3 |
| 12/31/2014 | CN104254521A 反式-2-癸烯酸衍生物及含有其的药物 Trans-2-decanoic acid derivative and a pharmaceutical containing it |
| 12/31/2014 | CN104254519A 新型的贝塔丙氨酸衍生物、药学上允许的盐及包含其作为有效成分的药物组合物 New beta-alanine derivatives, pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising as an active ingredient |
| 12/31/2014 | CN104254518A 线性肽抗生素 Linear peptide antibiotics |
| 12/31/2014 | CN104254517A 新的基于磺酸盐的曲美布汀盐 Based on the new Trimebutine sulfonate salt |
| 12/31/2014 | CN104254511A 紫外线吸收剂 UV absorbers |
| 12/31/2014 | CN104254343A 参与调节胶质细胞生成的fam19a5的医药用途 Involved in the regulation of glial cells generated fam19a5 medicinal use |
| 12/31/2014 | CN104254338A 用于治疗尿失禁和遗尿症的药物组合物 For the treatment of urinary incontinence and enuresis pharmaceutical compositions |
| 12/31/2014 | CN104254334A 胶囊配制品 Capsule formulations |
| 12/31/2014 | CN104254333A 18-甲基-15β,16β-亚甲基-19-去甲-20-螺氧-4-烯-3-酮系统的子宫内应用、包含18-甲基-15β,16β-亚甲基-19-去甲-20-螺氧-4-烯-3-酮的子宫内系统及其在避孕和妇科治疗中的用途 18- methyl -15β, 16β- methylene-19-nor-20- spiro-oxo-4-en-3-one in utero system application, comprising 18-methyl -15β, 16β- methylene - 19-nor-20- intrauterine system spiro-oxo-4-en-3-one and their use in contraception and the treatment of gynecological |
| 12/31/2014 | CN104254332A 使用甲基纳曲酮口服组合物治疗和预防阿片类诱发型便秘的方法 Use of oral methylnaltrexone compositions for treating and preventing opioid-induced constipation |
| 12/31/2014 | CN104254331A 用于鼻内施用唑吡坦的治疗组合物 For intranasal administration of zolpidem therapeutic compositions |
| 12/31/2014 | CN104254330A 具有激酶抑制活性的tryptoline衍生物及其用途 Having kinase inhibitory activity tryptoline derivatives and their use |
| 12/31/2014 | CN104254329A 用于治疗神经病变的含α-硫辛酸与和厚朴酚的组合物 For the treatment of neuropathy with lipoic acid compositions containing α- and magnolol |
| 12/31/2014 | CN104254328A Cgrp应答性促进剂 Cgrp responsive accelerator |
| 12/31/2014 | CN104254327A 治疗纤维化的方法 Fibrosis treatment method |
| 12/31/2014 | CN104254326A 4-氧代-2-戊烯酸和心血管健康 4- oxo-2-pentenoic acid and cardiovascular health |
| 12/31/2014 | CN104254325A 双胍组合物和治疗代谢性病症的方法 Biguanide compositions and methods for treating metabolic disorders |
| 12/31/2014 | CN104254322A 片剂 Tablet |
| 12/31/2014 | CN104254321A 稳定性提高的药物制剂 Improved stability of pharmaceutical preparations |
| 12/31/2014 | CN104254319A 即可灌注的吉西他滨溶液 To gemcitabine infusion solution |
| 12/31/2014 | CN104254317A 生发剂 Hair restorer |
| 12/31/2014 | CN104250308A 一种活性多糖的提取方法及其应用 An active polysaccharide extraction method and its application |
| 12/31/2014 | CN104250280A 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物 Antioxidant Inflammation Modulators: c-17 homologation oleanolic acid derivatives |
| 12/31/2014 | CN104250257A 3,4-二氢-1H-苯并[c][1,2]噁硼酸类化合物或其可药用盐及其制备方法和用途 -1H- 3,4-dihydro-benzo [c] [1,2] evil borate compound or a pharmaceutically acceptable salts and their preparation and use |
| 12/31/2014 | CN104250255A 一种柔性内酰胺类大环分子及其制备方法 A flexible lactam macrocyclic molecule and its preparation method |